Focusing on the world of Norwegian Opioid Substitution Treatment (OST) in the aftermath of significant reforms, this book casts a critical light on the intersections between medicine and law, and the ideologies infusing the notions of "individual choice" and "patient involvement" in the field of addiction globally. With ethnographic attention to the encounters between patients, clinicians, and bureaucrats, the volume shows that OST sustains the realities it is meant to address. The chapters follow one particular patient through complex clinical and legal battles as they fight to achieve a better quality of life. The study provides ethnographic insight that captures the individual, experiential aspects of addiction treatment, and how these experiences find a register within different domains of treatment and policy, including the familial, social, legal, and clinical. Offering a rare view of addiction treatment in a Scandinavian welfare state, this book will be of interest to scholars of medical and legal anthropology and sociology, and others with an interest in drug policy and addiction treatment.

A fully revised and updated edition of this unique and authoritative reference The award-winning A Guide to Treatments that Work , published in 1998, was the first book to assemble the numerous advances in both clinical psychology and psychiatry into one accessible volume. It immediately established itself as an indispensable reference for all mental health practitioners. Now in a fully updated edition,A Guide to Treatments that Work, Second Edition brings together, once again, a distinguished group of psychiatrists and clinical psychologists to take stock of which treatments and interventions actually work, which don't, and what still remains beyond the scope of our current knowledge. The new edition has been extensively revised to take account of recent drug developments and advances in psychotherapeutic interventions. Incorporating a wealth of new information, these eminent researchers and clinicians thoroughly review all available outcome data and clinical trials and provide detailed specification of methods and procedures to ensure effective treatment for each major DSM-IV disorder. As an interdisciplinary work that integrates information from both clinical psychology and psychiatry, this new edition will continue to serve as an essential volume for practitioners of every kind: psychiatrists, psychologists, clinical social workers, counselors, and mental health consultants.

"These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. " - p. iv

EPDF and EPUB available Open Access under CC-BY-NC-ND licence. Human service work is performed in many places – hospitals, shelters, households, prisons, schools, clinics – and is characterised by a complex mixture of organising principles, relations and rules. Using ethnographic methods, researchers can investigate these site-specific complexities, providing multi-dimensional and compelling analyses. Bringing together both theoretical and practical material, this book shows researchers how ethnography can be carried out within human service settings. It provides an invaluable guide on how to apply ethnographic creativeness and offers a more humanistic and context-sensitive approach in the field of health and social care to generating valid knowledge about today’s service work.

In an effort to make knowledge available about how treatment systems for drug users are organised in different countries, and to facilitate bi- and multilateral co-operation and research, this publication presents an overview of the treatment systems of 22 of the 35 Pompidou Group member countries. In most of Europe, The focus of drug treatment in the 1980s and 1990s was on heroin And The introduction of substitution treatment. However, a shift to cater for polydrug use is now taking place across Europe. The diversity of treatment systems reflects the complexity of the local legal, political, economic and cultural context of drug problems. This source of good practices for making treatment accessible and available will be useful not only for policy makers and practitioners, but also for user groups, researchers And The wider public as well

With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher.

Drug Abuse Treatment: A National Study of Effectiveness

In the 1960s, as illegal drug use grew from a fringe issue to a pervasive public concern, a new industry arose to treat the addiction epidemic. Over the next five decades, the industry's leaders promised to rehabilitate the casualties of the drug culture even as incarceration rates for drug-related offenses climbed. In this history of addiction treatment, Claire D. Clark traces the political shift from the radical communitarianism of the 1960s to the conservatism of the Reagan era, uncovering the forgotten origins of today's recovery movement. Based on extensive interviews with drug-rehabilitation professionals and archival research, The Recovery Revolution locates the history of treatment activists' influence on the development of American drug policy. Synanon, a controversial drug-treatment program launched in California in 1958, emphasized a community-based approach to rehabilitation. Its associates helped develop the therapeutic community (TC) model, which encouraged peer confrontation as a path to recovery. As TC treatment pioneers made mutual aid profitable, the model attracted powerful supporters and spread rapidly throughout the country. The TC approach was supported as part of the Nixon administration's "law-and-order" policies, favored in the Reagan administration's antidrug campaigns, and remained relevant amid the turbulent drug policies of the late twentieth and early twenty-first centuries. While many contemporary critics characterize American drug policy as simply the expression of moralizing conservatism or a mask for racial oppression, Clark recounts the complicated legacy of the "ex-addict" activists who turned drug treatment into both a product and a political symbol that promoted the impossible dream of a drug-free America.

Mathilde van den Brink.

Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are the clinical, ethical and psychopathological implications of these deaths? In this book, Shane Darke and his team provide the first full, synthetic review of the epidemiology, causes, prevalence, demography, and associated risk factors of illicit-drug-related mortality. In addition, they examine and evaluate interventions to reduce these deaths. The major causes of death among illicit drug users are overdose, disease, suicide and trauma. Each is independently examined. This is an important book for all clinicians and policy-makers involved in issues relating to illicit drug use.